Initiator Pharma announces last day of trading in warrants of series TO 2
The exercise period for warrants of series TO 2 (“TO 2”), which were issued in connection with Initiator Pharma A/S's (“Initiator Pharma” or “the Company”) rights issue and directed issue of units in June 2020, runs until the 15[th] of December 2020. The last day of trading in TO 2 is tomorrow, Friday the 11[th] of December 2020. Holders of TO 2 have the right to, for each warrant, subscribe for one new share in Initiator Pharma at a price of SEK 4.90. Upon full exercise of all warrants, Initiator Pharma will receive approximatelySEK 16.4 million before issue costs – capital that will be